On Thursday, the Food and Drug Administration will hold a public hearing to consider the stories of women like Hughes, who claim they have been seriously harmed by the permanent birth-control device. The agency called the meeting earlier this year amid mounting reports of complications linked to the device — more than 5,000 at last count — and a long-running social media campaign by women who want Essure pulled from the market.
FDA to Review Safety of Controversial Women’s Sterilization Device
